# Dose Systemic Lidocaine Improve the Quality of Recovery After Colorectal Endoscopic Submucosal Dissection

> **NCT05750056** · PHASE4 · COMPLETED · sponsor: **Fujian Provincial Hospital** · enrollment: 234 (actual)

## Conditions studied

- Postoperative Recovery

## Interventions

- **DRUG:** lidocaine
- **DRUG:** 0.9% saline
- **DRUG:** Propofol
- **DRUG:** Sufentanil

## Key facts

- **NCT ID:** NCT05750056
- **Lead sponsor:** Fujian Provincial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-24
- **Primary completion:** 2024-03-29
- **Final completion:** 2024-04-05
- **Target enrollment:** 234 (ACTUAL)
- **Last updated:** 2024-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05750056

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05750056, "Dose Systemic Lidocaine Improve the Quality of Recovery After Colorectal Endoscopic Submucosal Dissection". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT05750056. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*